Unknown

Dataset Information

0

Effect of high-dose oral rabeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.


ABSTRACT: Background. The aim of this study was to compare the effect of high-dose oral rabeprazole versus high-dose IV PPI on rebleeding after endoscopic treatment of bleeding peptic ulcers. Methods. This was a two-center, prospective, randomized, controlled trial. Patients with a high-risk bleeding peptic ulcer had endoscopic hemostasis and were randomly assigned to the high-dose oral rabeprazole group (20?mg twice daily for 72 hours) or the high-dose IV omeprazole group (80?mg as a bolus injection followed by continuous infusion at 8?mg/h for 72 hours). Results. The study was stopped because of slow enrollment (total n = 106). The rebleeding rates within 3 days were 3.7% (2 of 54 patients) given oral rabeprazole and 1.9% (1 of 52 patients) given IV omeprazole (P = 1.000). The rebleeding rates after 3 days were 1.9% and 0% (P = 1.000), respectively. The surgical intervention rates were 3.7% and 0% (P = 0.495), and the mortality rates were 1.9% and 0% (P = 1.000), respectively. Conclusions. The effect of high-dose oral rabeprazole did not differ significantly from that of high-dose IV omeprazole on rebleeding, surgical intervention, or mortality after endoscopic treatment of bleeding peptic ulcers, but this requires further evaluation.

SUBMITTER: Kim HK 

PROVIDER: S-EPMC3463177 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5612665 | BioStudies
2020-01-01 | S-EPMC7223755 | BioStudies
2016-01-01 | S-EPMC4798837 | BioStudies
2016-01-01 | S-EPMC5369541 | BioStudies
2015-01-01 | S-EPMC4454079 | BioStudies
1999-01-01 | S-EPMC1727515 | BioStudies
2014-01-01 | S-EPMC4110066 | BioStudies
2015-01-01 | S-EPMC4616719 | BioStudies
2012-01-01 | S-EPMC3503825 | BioStudies
1000-01-01 | S-EPMC5395769 | BioStudies